Aflac Incorporated (AFL) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S.
Total Cash From Operating Activities Chart for Aflac Incorporated
Aflac Incorporated (AFL) operating cash flow for FY2025 was USD 2.6B, a -5.6% change from FY2024. Aflac Incorporated's operating cash flow grew from USD 867.3M in 1989 to USD 2.6B in 2025 (194.6% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -15.6%, 10-year CAGR of -9.3%, 20-year CAGR of -2.7%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $60.89B
- Implied Share Price
- $121.45
- Enterprise Value
- $70.84B
- Revenue (TTM)
- $18.07B
- EBITDA
- $6.06B
- Profit Margin
- 26.91%
- Trailing P/E
- 13.10
- Forward P/E
- 14.53
- Price/Book (MRQ)
- 2.01
- Price/Sales (TTM)
- 3.37
- EV/EBITDA
- 0.00
- EV/Revenue
- 3.87
- Dividend Yield
- 1.97%
- Book Value
- $60.35
- Free Cash Flow (FY2025)
- $2.56B
- Free Cash Flow Yield
- 4.20%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.